Cognitive impairment in Huntington disease: diagnosis and treatment.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Paulsen JS;Paulsen JS
  • Source:
    Current neurology and neuroscience reports [Curr Neurol Neurosci Rep] 2011 Oct; Vol. 11 (5), pp. 474-83.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Current Science Inc Country of Publication: United States NLM ID: 100931790 Publication Model: Print Cited Medium: Internet ISSN: 1534-6293 (Electronic) Linking ISSN: 15284042 NLM ISO Abbreviation: Curr Neurol Neurosci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: Philadelphia, PA : Current Science Inc., c2001-
    • Subject Terms:
    • Abstract:
      Cognition has been well characterized in the various stages of Huntington disease (HD) as well as in the prodrome before the motor diagnosis is given. Although the clinical diagnosis of HD relies on the manifestation of motor abnormalities, the associated impairments have been growing in prominence for several reasons. First, research to understand the most debilitating aspects of HD has suggested that cognitive and behavioral changes place the greatest burden on families, are most highly associated with functional decline, and can be predictive of institutionalization. Second, cognitive impairments are evident at least 15 years prior to the time at which motor diagnosis is given. Finally, cognitive decline is associated with biological markers such as brain atrophy, circulating levels of brain-derived neurotrophic factors, and insulin-like growth factor 1. Efforts are now underway to develop valid and reliable measures of cognition in the prodrome as well as in all stages of HD so that clinical trials can be conducted using cognitive outcomes.
    • References:
      J Psychiatry Neurosci. 2006 Jan;31(1):21-9. (PMID: 16496032)
      Neurology. 2001 Aug 28;57(4):658-62. (PMID: 11524475)
      Future Neurol. 2010 Jan;5(1):. (PMID: 24348095)
      Exp Brain Res. 2005 Sep;165(4):454-60. (PMID: 15875168)
      J Neuropsychiatry Clin Neurosci. 2001 Summer;13(3):342-6. (PMID: 11514640)
      Science. 1985 Nov 1;230(4725):561-3. (PMID: 2931802)
      Neuropsychologia. 2008 Sep;46(11):2638-49. (PMID: 18533200)
      Arch Neurol. 2006 Jun;63(6):883-90. (PMID: 16769871)
      PLoS Curr. 2011 Jul 11;3:RRN1241. (PMID: 21826116)
      Arch Clin Neuropsychol. 2011 Feb;26(1):59-66. (PMID: 21147861)
      Mov Disord. 2011 Apr;26(5):877-84. (PMID: 21370269)
      Lancet Neurol. 2011 Jan;10(1):31-42. (PMID: 21130037)
      Brain Res Bull. 2010 May 31;82(3-4):201-7. (PMID: 20385209)
      Neuropsychologia. 2008;46(8):2152-60. (PMID: 18407301)
      Cogn Behav Neurol. 2005 Jun;18(2):102-7. (PMID: 15970729)
      PLoS Curr. 2011 Oct 25;3:RRN1250. (PMID: 22120841)
      J Clin Exp Neuropsychol. 2007 May;29(4):365-76. (PMID: 17497560)
      Neurology. 2007 May 15;68(20):1710-7. (PMID: 17502553)
      Neurol Sci. 2003 Feb;23(6):287-93. (PMID: 12624715)
      Mov Disord. 2006 Mar;21(3):385-9. (PMID: 16211608)
      Biol Psychiatry. 2006 Jan 1;59(1):57-63. (PMID: 16112655)
      AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1715-21. (PMID: 15569736)
      J Clin Exp Neuropsychol. 2010 Mar;32(3):231-8. (PMID: 19484645)
      Mov Disord. 2010 Oct 15;25(13):2229-33. (PMID: 20721924)
      Mov Disord. 2009 Sep 15;24(12):1763-72. (PMID: 19562761)
      PLoS Curr. 2011 Jun 17;3:RRN1242. (PMID: 21731882)
      Int J Lang Commun Disord. 2010 May-Jun;45(3):381-93. (PMID: 20144006)
      Neuropsychologia. 2006;44(10):1984-94. (PMID: 16797615)
      Neurosci Lett. 1991 Dec 9;133(2):257-61. (PMID: 1840078)
      J Nurs Meas. 2010;18(2):83-99. (PMID: 20806651)
      J Clin Exp Neuropsychol. 2011 Jun;33(5):567-79. (PMID: 21302170)
      Int J Lang Commun Disord. 2010 Nov-Dec;45(6):656-69. (PMID: 20085535)
      Psychol Bull. 1990 Nov;108(3):420-41. (PMID: 2270236)
      Neuropsychology. 1999 Jul;13(3):381-8. (PMID: 10447299)
      J Int Neuropsychol Soc. 1995 May;1(3):281-90. (PMID: 9375222)
      Neurology. 2004 Jul 13;63(1):66-72. (PMID: 15249612)
      J Clin Exp Neuropsychol. 1995 Oct;17(5):654-67. (PMID: 8557807)
      J Int Neuropsychol Soc. 2007 May;13(3):539-43. (PMID: 17445303)
      Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006455. (PMID: 19588392)
      Neuropsychologia. 2011 Jan;49(2):264-70. (PMID: 21094653)
      J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10. (PMID: 20884680)
      Int J Lang Commun Disord. 2010 Sep-Oct;45(5):523-36. (PMID: 20874057)
      Neurol Sci. 2001 Feb;22(1):105-6. (PMID: 11487181)
      Brain. 2011 Jan;134(Pt 1):137-42. (PMID: 20923788)
      Neurology. 2005 Sep 13;65(5):745-7. (PMID: 16157910)
      J Int Neuropsychol Soc. 2007 Sep;13(5):758-69. (PMID: 17697407)
      Int J Lang Commun Disord. 2002 Oct-Dec;37(4):459-74. (PMID: 12396844)
      Mov Disord. 1996 Mar;11(2):136-42. (PMID: 8684382)
      J Clin Psychol. 1995 Jan;51(1):48-58. (PMID: 7782475)
      J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):379-84. (PMID: 19726414)
      Orphanet J Rare Dis. 2010 Dec 20;5:40. (PMID: 21171977)
      Neuropsychologia. 2008 Jan 15;46(1):369-73. (PMID: 18061217)
      Neuropsychology. 2011 Jan;25(1):1-14. (PMID: 20919768)
      Mov Disord. 2011 Aug 1;26(9):1711-6. (PMID: 21538527)
      Lancet Neurol. 2011 Jan;10(1):83-98. (PMID: 21163446)
      Arch Clin Neuropsychol. 1996;11(4):295-302. (PMID: 14588934)
      Arch Clin Neuropsychol. 2007 Jan;22(1):15-24. (PMID: 17142007)
      J Clin Psychopharmacol. 2009 Oct;29(5):484-7. (PMID: 19745649)
      Neurology. 2010 Dec 14;75(24):2150-60. (PMID: 21068430)
      Neurology. 2006 Nov 14;67(9 Suppl 3):S12-3. (PMID: 17101927)
      Biomark Med. 2010 Dec;4(6):871-87. (PMID: 21133708)
      Psychiatry Res. 2012 Apr 30;196(2-3):309-14. (PMID: 22397915)
      Arch Neurol. 1998 Jun;55(6):801-5. (PMID: 9626771)
      Neuropsychologia. 2010 Jul;48(9):2719-29. (PMID: 20580641)
      Mov Disord. 2008 Oct 15;23(13):1830-6. (PMID: 18785217)
      J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):120-2. (PMID: 12486282)
      Neuropsychologia. 2007 Apr 9;45(8):1767-76. (PMID: 17303196)
      J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207. (PMID: 20463114)
      Neuropsychology. 2010 Jul;24(4):435-42. (PMID: 20604618)
      J Int Neuropsychol Soc. 1999 Nov;5(7):609-15. (PMID: 10645703)
      Neuropsychology. 2004 Oct;18(4):692-9. (PMID: 15506837)
      J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80. (PMID: 18096682)
      Clin Neuropsychol. 2011 Jul;25(5):757-77. (PMID: 21660882)
      Exp Psychol. 2011;58(6):434-42. (PMID: 21592942)
      PLoS Curr. 2011 Jun 14;2:RRN1244. (PMID: 21804956)
      Cell. 1993 Mar 26;72(6):971-83. (PMID: 8458085)
      Neurotherapeutics. 2008 Apr;5(2):181-97. (PMID: 18394562)
      Nature. 2010 Jul 22;466(7305):457-62. (PMID: 20651684)
      Neurology. 1995 May;45(5):951-6. (PMID: 7746413)
      Neurology. 2010 Jul 6;75(1):57-63. (PMID: 20603485)
      Brain. 2007 Jul;130(Pt 7):1732-44. (PMID: 17584778)
      J Nerv Ment Dis. 2004 Jan;192(1):72-4. (PMID: 14718780)
      Mov Disord. 2010 Jul 15;25(9):1163-9. (PMID: 20629124)
      Neurology. 2009 Mar 31;72(13):1116-7. (PMID: 19332688)
      J Clin Exp Neuropsychol. 1999 Jun;21(3):341-51. (PMID: 10474173)
      Neuropsychologia. 2010 Jan;48(1):171-8. (PMID: 19747497)
    • Grant Information:
      R01 NS040068 United States NS NINDS NIH HHS; R01 NS054893 United States NS NINDS NIH HHS; R01 NS040068-11 United States NS NINDS NIH HHS
    • Publication Date:
      Date Created: 20110824 Date Completed: 20120110 Latest Revision: 20231106
    • Publication Date:
      20240513
    • Accession Number:
      PMC3628771
    • Accession Number:
      10.1007/s11910-011-0215-x
    • Accession Number:
      21861097